Institutional investors hold a majority ownership of CELG through the 80.93% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2016, these large investors purchased a net $10.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
UBS ASSET MANAGEMENT (AMERICAS) ... Bought 3.0 Million shares of Celgene
VOYA INVESTMENT MANAGEMENT CO. L... Bought 1.9 Million shares of Celgene
CITADEL ADVISORS LLC Bought 1.6 Million shares of Celgene